# Slo-1K channels, TRP-2 channels, emodepside and diethylcarbamazine in Filaria

> **NIH NIH R01** · IOWA STATE UNIVERSITY · 2024 · $469,119

## Abstract

Project Summary
Filariases are a group of neglected tropical diseases produced by infection with microfilaria of Clade III
parasitic nematodes that are transmitted by biting insects. One example is the lymphatic filariasis
produced by Brugia malayi. Lymphatic filariasis is a debilitating and disfiguring disease which occurs in
120 million people worldwide. Other filarial diseases are River Blindness produced by Onchocerca
volvulus and loiasis produced by Loa loa. Prevention and treatment of these nematode parasite diseases
relies on the use of anthelmintic drugs because no effective vaccines are available. Prophylaxis using
Mass Drug Administration [MDA] programs are limited by the efficacy of existing anthelmintics.
Diethylcarbamazine is a mainstay for the treatment of lymphatic filariasis and loiasis in most parts of the
world, except in areas where onchocerciasis is present because it is contra-indicated by risks of blindness.
Diethylcarbamazine produces rapid clearance of microfilaria and causes ~40% mortality of adult parasites
(macrofilaricide). A number of studies have suggested that diethylcarbamazine has an indirect host-
mediated mode of action and that diethylcarbamazine acts by changing host arachidonic acid pathways.
We have observed that diethylcarbamazine has direct effects on filarial nematodes. We present
preliminary observations that show that diethylcarbamazine increases the opening of TRP-2 channels in
Brugia malayi, and opening of calcium-activated SLO-1 K channels. The effect is a rapid, transient
inhibition of motility followed by recovery: the response accommodates.
Emodepside is an emerging and important cyclooctadepsipeptide class of anthelmintic that also has
effects on microfilaria and adult filaria. Emodepside treatments could allow a major advance over existing
mass drug administration (MDA) programs which require regular treatments to kill adult parasites. One
of the sites of action of emodepside is on nematode SLO-1 K channels where opening of the channels
inhibits motility, but it is not effective against all filaria. Here we propose to compare effects on filarial SLO-
1 K channels from Brugia, Onchocerca and Loa and to examine actions and interactions of these two
drugs to explore their mode of action.
We have 3 aims:
Aim #1: Characterize, in vitro, the concentration motility-inhibition-response relationships of
diethylcarbamazine and emodepside and their combination on: A) Brugia microfilaria; B) Brugia
adult females; C) Brugia adult males.
We will test the hypothesis that effects of diethylcarbamazine
and emodepside are additive, synergistic or antagonistic and dependent of life-cycle stage and sex.
Aim #2 Characterize the SLO-1 K channel current responses to diethylcarbamazine and
emodepside in isolated Brugia malayi muscle flaps under patch-clamp
 We will test the hypotheses:
a) that the effects of emodepside and diethylcarbamazine interact; b) that the interactions of
diethylcarbamazine and emodepside are de...

## Key facts

- **NIH application ID:** 10899540
- **Project number:** 5R01AI155413-05
- **Recipient organization:** IOWA STATE UNIVERSITY
- **Principal Investigator:** Richard John Martin
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $469,119
- **Award type:** 5
- **Project period:** 2020-09-16 → 2026-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10899540

## Citation

> US National Institutes of Health, RePORTER application 10899540, Slo-1K channels, TRP-2 channels, emodepside and diethylcarbamazine in Filaria (5R01AI155413-05). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10899540. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
